Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2023-11-29
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primarily, to investigate the effectiveness of the RISE blended behaviour change intervention in people with a first stroke to prevent major adverse cardiovascular events (i.e., recurrent stroke or TIA, acute coronary events and cardiovascular death, MACE) after 1 year follow-up compared to standard care, and cost-effectiveness. For this aim, 376 persons are enrolled in the experimental group and 376 in the control group. Considering loss to follow up, it is expected that around 950-1000 patients need to be included during baseline measurement in total.
Additionally, to determine the effectiveness of the RISE intervention on reducing sedentary behaviour after discharge from acute hospital care in community dwelling people with a first-ever stroke, who have a sedentary movement behavioural pattern (so called 'sedentary prolongers' and 'sedentary movers') in comparison to usual care, at the end of the intervention period (T1). For this aim, 59 persons are enrolled in the experimental group and 59 in the control group. Considering loss to follow up, it is expected that around 197 patients need to be included during baseline measurement in total.
Who can participate? People aged over 18, who return home after acute care with a first-ever stroke, who are independent in walking with or without a walking aid, will be included in the RISE intervention study.
What does the study involve? In this clinical randomized controlled trial, participants with first-ever stroke and a sedentary movement pattern will be included and randomly assigned to either the experimental group who will receive RISE intervention and usual care or the control group who will receive usual care. Primary and secondary outcome will be measured at baseline, post-treatment and six, nine and 12 months post-randomisation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retaining Short-term Training Effects on Gait Adaptability in People With Stroke
NCT05825053
Proactive and Reactive Balance Training Effects on Balance and Functional Performance Among Chronic Stroke Survivors
NCT06192485
Improving Propulsion of the Paretic Leg In Chronic Stroke
NCT04650802
Adaptive Sports for Individuals With a Physical Disability : Effect Among Stroke Survivors
NCT05443529
MONitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke
NCT05793177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To determine the effectiveness of the RISE intervention on preventing major adverse cardiovascular effects (MACE), after discharge from acute hospital care in community dwelling people after first-ever stroke, who have a sedentary movement behavioural pattern. In addition, the effects on 24h activity pattern, cost-effectiveness, and usability of the RISE intervention will be investigated.
Study design: In this clinical randomized controlled trial, participants with first-ever stroke and a sedentary movement pattern will be included and randomly assigned to either the experimental group who will receive RISE intervention and usual care or the control group who will receive usual care. Primary and secondary outcomes will be measured at baseline, post-treatment (four months), and six, nine, and 12 months post-randomisation.
Study population: People aged over 18, who return home after acute care with a first-ever stroke, who are independent in walking with or without a walking aid, will be included in the RISE intervention study.
Intervention (if applicable): Participants will receive the RISE intervention, a 15-weeks blended behavioural intervention, where a primary care physiotherapist coaches participants on striking the balance in their 24h activity pattern, with a focus on reducing and interrupting their sedentary time. This will subsequently lead to an increase in physical activity. Next to that, insights into their personal sleep pattern, sleep hygiene rules and advices will be provided. Primary care physiotherapists coach people with a first-ever stroke in their home setting by using behaviour change techniques and the RISE eCoaching system. The RISE eCoaching system consists of 1) an activity monitor, 2) a smartphone application that provides real-time feedback and contains e-learning modules, 3) a monitoring dashboard for the physiotherapist. Participants receive participatory support from someone from their social network (e.g., partner or close friend) who joins them in the intervention (see image 1).
Participants in the control group receive usual care, according to hospital specific guidelines.
Main study parameters/endpoints: Effectiveness of RISE intervention on preventing major adverse cardiovascular events.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden and risk of participating in the RISE intervention are considered low. The participants will receive a blended coaching intervention to reduce and interrupt their sedentary behaviour. The blended intervention includes ten face-to-face or online sessions of a primary care physiotherapist, wearing an activity monitor during the intervention period, and support from the smartphone application. During the intervention people will be encouraged to sit less and move more. The participant will participate in a baseline and post intervention measurements. This includes wearing an activity monitor, questionnaires and performing physical tests. All measurements are non-invasive. Participants can shower and perform all other daily activities while wearing the activity monitor. The other measurements will take about 3.5 hours in total, and will be carried out online or at people\'s homes. Included participants are physically capable of performing these physical activities and are coached by a physiotherapist. Therefore, the risk involved in participating is low. Additional burden of the intervention is low since visits of the physiotherapist will be at home or online
The possible benefits of participating in the study are: 1) insights in own movement behaviour and 2) (if someone is randomized to the RISE intervention group) the RISE intervention may help to reduce sedentary time, which may lower the risk on recurrent stroke.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
RISE intervention and usual care
RISE intervention
The RISE intervention: a 15-weeks blended behavioral intervention, where a primary care physiotherapist coaches participants on striking the balance in their 24h activity pattern, with a focus on reducing and interrupting their sedentary time. This will subsequently lead to an increase in physical activity. Next to that, insights into their personal sleep pattern, sleep hygiene rules and advices will be provided.
Primary care physiotherapists coach people with a first-ever stroke in their home setting by using behavior change techniques and the RISE eCoaching system. The RISE eCoaching system consists of 1) an activity monitor, 2) a smartphone application that provides real-time feedback and contains e-learning modules, 3) a monitoring dashboard for the physiotherapist. Participants receive participatory support from someone from their social network (e.g., partner or close friend) who joins them in the intervention.
Control group
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RISE intervention
The RISE intervention: a 15-weeks blended behavioral intervention, where a primary care physiotherapist coaches participants on striking the balance in their 24h activity pattern, with a focus on reducing and interrupting their sedentary time. This will subsequently lead to an increase in physical activity. Next to that, insights into their personal sleep pattern, sleep hygiene rules and advices will be provided.
Primary care physiotherapists coach people with a first-ever stroke in their home setting by using behavior change techniques and the RISE eCoaching system. The RISE eCoaching system consists of 1) an activity monitor, 2) a smartphone application that provides real-time feedback and contains e-learning modules, 3) a monitoring dashboard for the physiotherapist. Participants receive participatory support from someone from their social network (e.g., partner or close friend) who joins them in the intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Aged 18 years or older;
2. All types of first-ever stroke diagnosed in hospital within six months before start of the RISE intervention;
3. Able to walk independently, as defined by a Functional ambulation categories score of at least 3;
4. Independent regarding activities of daily living pre-stroke, as defined by a Barthel Index score of \>18;
5. Discharged to the home-setting;
6. Not participating in a physical rehabilitation program lasting ≥ 3 months;
7. Given their written informed consent.
Exclusion Criteria
1. The participant has insufficient knowledge or is cognitively unable to understand the Dutch language of the intervention content;
2. The participant has severe comorbidities that withhold that person from safely reducing and interrupting their sedentary time (e.g. sever pulmonary diseases, hart failure or malignity's) as determined with the Physical Activity Readiness Questionnaire;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martijn F. Pisters, PhD, PT
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martijn F Pisters, Dr.
Role: PRINCIPAL_INVESTIGATOR
UMC Utrecht Brain Center and Fontys University of Applied Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fysio 4 Den Bosch
's-Hertogenbosch, North Brabant, Netherlands
Meras & Vital Fysiotherapie
Eersel, North Brabant, Netherlands
PMC Eindhoven
Eindhoven, North Brabant, Netherlands
Stroomz Prinsejagt
Eindhoven, North Brabant, Netherlands
Fysiotherapie Zesgehuchten
Geldrop, North Brabant, Netherlands
JVDI De Fysioclub
Helmond, North Brabant, Netherlands
Fysiotherapie Rakthof
Helmond, North Brabant, Netherlands
Vivent
Rosmalen, North Brabant, Netherlands
Van Hoof, centrum voor therapie en gezondheid
Valkenswaard, North Brabant, Netherlands
Fysio Annette de Gooijer
Vlijmen, North Brabant, Netherlands
Fysiofit Vught
Vught, North Brabant, Netherlands
Fysio Vught Noord
Vught, North Brabant, Netherlands
Fysiotherapie Beelen
Breukelen, Utrecht, Netherlands
Fysiotherapie Zorgspectrum Houten eerstelijn
Houten, Utrecht, Netherlands
Fysiotherapie Groene Biezen
IJsselstein, Utrecht, Netherlands
MTCFysio
Mijdrecht, Utrecht, Netherlands
Leidsche Rijn Julius Gezondheidscentra
Utrecht, Utrecht, Netherlands
Rembrandt fysiotherapie en revalidatie
Veenendaal, Utrecht, Netherlands
Fysio Frankenhof
Wijk bij Duurstede, Utrecht, Netherlands
Synergy Fysiotherapie
Woerden, Utrecht, Netherlands
Van Tongeren Fysiotherapeuten
Zeist, Utrecht, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eline Geurts
Role: primary
Tamara van Leeuwarden
Role: primary
Marjolein Dings
Role: primary
Bram van Gompel
Role: primary
Evelien Mulder
Role: primary
Laura Pleiter
Role: primary
Jenny Bijsterbosch
Role: primary
José Martens
Role: primary
Wencke van Deurzen
Role: primary
Jytte Blenkers
Role: primary
Yvon Hagoort
Role: primary
Nikita Huijgens
Role: backup
Iris van Bussel
Role: primary
Martje Jans
Role: primary
Marielle Wittekamp
Role: primary
Jelmer Klomp
Role: primary
Esther Verdam
Role: primary
Sander Perry
Role: primary
Tessa Hodes
Role: primary
Liselot De Bruijn-Oechies
Role: primary
Martje Jans
Role: primary
Annemarie de Wissel
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Biemans CFM, Hartman YAW, Broers S, Pagen S, Hendrickx W; RISE Study Group; van Dongen JM, Verschuren OW, English C, Veenhof C, Visser-Meily JMA, Pisters MF. Secondary prevention by striking the balance in 24-hour movement behaviour by empowering people at risk with a stroke: rationale and design of the RISE intervention randomised controlled trial. BMJ Open. 2025 Jun 5;15(6):e094894. doi: 10.1136/bmjopen-2024-094894.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAAK.PRO04.093
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
10930012310010
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NL83940.000.23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.